📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: InspireMD

1.1 - Company Overview

InspireMD Logo

InspireMD

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of medical device solutions focused on proprietary stent system technology (MGuard), including CGuard EPS, a carotid stent using MicroNet mesh to trap and seal thrombus and plaque to help prevent stroke, and SwitchGuard NPS, a neuroprotection system intended for Transcarotid Artery Revascularization (TCAR) procedures, currently under clinical trial.

Products and services

  • MicroNet Mesh Technology: A mesh-based stroke-prevention technology that traps and seals thrombus and plaque within carotid stent constructs to help prevent stroke during carotid interventions
  • CGuard EPS: A carotid-specific stent system engineered to prevent stroke by employing MicroNet mesh that traps and seals thrombus and plaque across the treated carotid segment
  • SwitchGuard NPS: A clinical-trial-stage neuroprotection system intended for use in Transcarotid Artery Revascularization (TCAR) procedures, supporting neuroprotection during transcarotid revascularization

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to InspireMD

Rapidscan Pharma Logo

Rapidscan Pharma

HQ: United States Website
  • Description: Provider of regadenoson, a pharmacological stress agent used in the diagnosis and risk stratification of cardiovascular disease, with licensed rights to sell in Europe and select territories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rapidscan Pharma company profile →
Xention Logo

Xention

HQ: United Kingdom Website
  • Description: Provider of ion channel-modulating drug discovery and development, offering therapeutics for atrial fibrillation, overactive bladder, pain, and autoimmune diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Xention company profile →
Nuubo Logo

Nuubo

HQ: Spain Website
  • Description: Provider of wireless, wearable technologies for physiological monitoring via the nECG DYNAMIC PLATFORM to perform and read electrocardiograms remotely. Offerings include the Nuubo Textile Electrode for high-quality ECG during daily activities, a 30-day Nuubo Monitoring Report, Nuubo Device Installation guidance, the myNuubo app for symptom tracking and charge reminders, and scientific research in validation, risk stratification, arrhythmias, and cardiac rehabilitation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nuubo company profile →
Okami Medical Logo

Okami Medical

HQ: United States Website
  • Description: Provider of devices for heart disease treatment, including the LOBO Vascular Occlusion System—a low-profile braided occluder enabling rapid, reliable peripheral artery vessel occlusion. Offerings include LOBO-3 (cleared for peripheral artery occlusion) and LOBO-5, LOBO-7, and LOBO-9 (FDA 510(k) cleared) for peripheral embolization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Okami Medical company profile →
Endosense Logo

Endosense

HQ: Switzerland Website
  • Description: Provider of medical technology to improve the efficacy, safety and reproducibility of catheter ablation for treating cardiac arrhythmias, including TactiCath, the first and only force-sensing ablation catheter that gives physicians a real-time, objective measure of contact force; CE marked in May 2009.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Endosense company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for InspireMD

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to InspireMD

2.2 - Growth funds investing in similar companies to InspireMD

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for InspireMD

4.2 - Public trading comparable groups for InspireMD

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to InspireMD

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About InspireMD

What does InspireMD do?

InspireMD is a provider of medical device solutions focused on proprietary stent system technology (MGuard), including CGuard EPS, a carotid stent using MicroNet mesh to trap and seal thrombus and plaque to help prevent stroke, and SwitchGuard NPS, a neuroprotection system intended for Transcarotid Artery Revascularization (TCAR) procedures, currently under clinical trial.

Who are InspireMD's competitors?

InspireMD's competitors and similar companies include Rapidscan Pharma, Xention, Nuubo, Okami Medical, and Endosense.

Where is InspireMD headquartered?

InspireMD is headquartered in United States.

How many employees does InspireMD have?

InspireMD has 1,000 employees 🔒.

When was InspireMD founded?

InspireMD was founded in 2010 🔒.

What sector and industry vertical is InspireMD in?

InspireMD is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for InspireMD

Who are the top strategic acquirers in InspireMD's sector and industry

Top strategic M&A buyers and acquirers in InspireMD's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for InspireMD?

Top strategic M&A buyers groups and sectors for InspireMD include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in InspireMD's sector and industry vertical

Which are the top PE firms investing in InspireMD's sector and industry vertical?

Top PE firms investing in InspireMD's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in InspireMD's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in InspireMD's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in InspireMD's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to InspireMD include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in InspireMD's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for InspireMD?

The key public trading comparables and valuation benchmarks for InspireMD include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for InspireMD for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for InspireMD with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in InspireMD's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for InspireMD with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in InspireMD's' sector and industry vertical?

Access recent funding rounds and capital raises in InspireMD's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for InspireMD